1. Home
  2. III vs NYXH Comparison

III vs NYXH Comparison

Compare III & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.34

Market Cap

187.8M

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.20

Market Cap

152.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
III
NYXH
Founded
2006
2009
Country
United States
Belgium
Employees
1500
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.8M
152.8M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
III
NYXH
Price
$4.34
$3.20
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$5.50
$9.33
AVG Volume (30 Days)
201.1K
48.4K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
4.16%
N/A
EPS Growth
216.67
N/A
EPS
0.19
N/A
Revenue
$192,745,000.00
N/A
Revenue This Year
$3.85
$214.32
Revenue Next Year
$4.34
$124.13
P/E Ratio
$22.84
N/A
Revenue Growth
4.51
N/A
52 Week Low
$3.57
$2.76
52 Week High
$6.45
$8.64

Technical Indicators

Market Signals
Indicator
III
NYXH
Relative Strength Index (RSI) 60.10 49.73
Support Level $4.12 $2.78
Resistance Level $5.14 $3.32
Average True Range (ATR) 0.12 0.19
MACD 0.08 0.06
Stochastic Oscillator 92.87 58.82

Price Performance

Historical Comparison
III
NYXH

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: